Credit Suisse Ag Allogene Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 93,461 shares of ALLO stock, worth $192,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,461

Previous 76,160 22.72%

Holding current value

$192,529

Previous $244,000 70.9%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.92 - $5.63 $50,518 - $97,404	17,301 Added 22.72%	93,461 $417,000
Q4 2023 Feb 08, 2024	SELL	$2.28 - $3.5 $20,478 - $31,437	-8,982 Reduced 10.55%	76,160 $244,000
Q3 2023 Nov 13, 2023	SELL	$3.17 - $5.96 $108,962 - $204,863	-34,373 Reduced 28.76%	85,142 $269,000
Q2 2023 Aug 11, 2023	BUY	$4.53 - $6.74 $61,947 - $92,169	13,675 Added 12.92%	119,515 $593,000
Q1 2023 May 10, 2023	BUY	$4.92 - $8.21 $16,801 - $28,037	3,415 Added 3.33%	105,840 $522,000
Q4 2022 Feb 13, 2023	BUY	$5.62 - $11.11 $113,006 - $223,399	20,108 Added 24.43%	102,425 $644,000
Q3 2022 Nov 10, 2022	BUY	$10.32 - $17.28 $9,556 - $16,001	926 Added 1.14%	82,317 $889,000
Q2 2022 Aug 12, 2022	BUY	$6.78 - $12.28 $94,228 - $170,667	13,898 Added 20.59%	81,391 $929,000
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $21,611 - $43,194	2,825 Added 4.37%	67,493 $615,000
Q4 2021 Feb 14, 2022	SELL	$13.13 - $24.52 $175,928 - $328,543	-13,399 Reduced 17.16%	64,668 $965,000
Q3 2021 Nov 12, 2021	BUY	$21.01 - $27.64 $86,035 - $113,185	4,095 Added 5.54%	78,067 $2.01 Million
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $274,433 - $418,251	11,683 Added 18.76%	73,972 $1.93 Million
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $1.8 Million - $2.73 Million	-69,875 Reduced 52.87%	62,289 $2.2 Million
Q4 2020 Feb 12, 2021	BUY	$25.24 - $43.45 $398,716 - $686,379	15,797 Added 13.58%	132,164 $3.34 Million
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $169,833 - $235,815	-5,245 Reduced 4.31%	116,367 $4.39 Million
Q2 2020 Aug 12, 2020	BUY	$18.39 - $54.04 $879,152 - $2.58 Million	47,806 Added 64.77%	121,612 $5.21 Million
Q1 2020 May 13, 2020	SELL	$18.22 - $28.25 $1.02 Million - $1.58 Million	-55,936 Reduced 43.11%	73,806 $1.43 Million
Q4 2019 Feb 12, 2020	BUY	$24.82 - $31.4 $2.74 Million - $3.47 Million	110,462 Added 572.94%	129,742 $3.37 Million
Q3 2019 Nov 12, 2019	BUY	$26.11 - $32.99 $138,879 - $175,473	5,319 Added 38.1%	19,280 $525,000
Q2 2019 Aug 14, 2019	BUY	$25.56 - $31.09 $356,843 - $434,047	13,961 New	13,961 $374,000

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $296M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account